Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof

Details for Australian Patent Application No. 2003230929 (hide)

Event Publications

14 August 2003 Complete Application Filed

Priority application(s): 60/372,277 12.04.02 US; 60/373,274 16.04.02 US

4 December 2003 Application Open to Public Inspection

Published as AU-A-2003230929

2 December 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Raven Biotechnologies, Inc. to Raven biotechnologies, inc.

21 September 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.